WST

West Pharmaceutical Services, Inc.

Stock · NYSE

Program summary

FieldValueAs ofSource
Current authorization$1.0bn30-Sep-2610-Q filed 29-Oct-26
Remaining authorization$315m30-Sep-2610-Q filed 29-Oct-26
Program expiryn/a—
Repurchased last quarter$231m30-Sep-2610-Q filed 29-Oct-26
Has used an ASRNo—

Programs

Authorized onAuthorizedRemainingExpiresTerms
Not found in filings$1.0bn$315mESTn/aIn February 2026, the Company’s Board of Directors authorized a new share repurchase program for the purchase of up to $1.0 billion of the Company’s common stock in open-market transactions, block transactions, through derivative transactions, privately negotiated transactions, or otherwise, including pursuant to any trading plan entered into by the Company under Rule 10b5-1 of the Exchange Act.10-Q filed 29-Oct-26

Open-market repurchases

Repurchased per month, USD (≈ shares × average price)
  1. Apr ’26
  2. May ’26
  3. Jun ’26
  4. Jul ’26
  5. ≈$113m
    Aug ’26
  6. ≈$55m
    Sep ’26
Month endedSharesAvg price≈ ValueSource
30-Sep-26154,301$355.79$55m10-Q filed 29-Oct-26
31-Aug-26323,689$349.61$113m10-Q filed 29-Oct-26
31-Jul-26185,521$339.09$63m10-Q filed 29-Oct-26
30-Jun-26129,966$328.13$43m10-Q filed 23-Jul-26
Filings through 30-Sep-26· checked 18-Nov-26